ArticleMacromolecular rapid communications2025
Efficient Solution-Phase Synthesis of Sequence-Defined Oligourethanes with Precise Chirality Control.
Article in Macromolecular rapid communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Precise Synthesis of Star-Shaped Redox-Responsive Segmented Polyurethanes with Controlled Arm Sequences for Drug Delivery.Precision chemistry · 2026Article
- Efficient Solution-Phase Synthesis of Sequence-Defined Oligourethanes with Precise Chirality Control.Macromolecular rapid communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nature relies on precisely defined macromolecules for complex biochemical processes with exceptional specificity and efficiency. To replicate these properties in synthetic systems, chemists have developed sequence-defined macromolecules-polymers with absolute control over monomer sequence and structure, enabling tailored functions. However, their exploration in material science remains limited due to the challenges of synthesis, which is often low-yielding and time-consuming. To address this, we designed and synthesized Fmoc-assisted stereo-controlled sequence-defined oligourethanes (SDOUs) in the solution phase. Our step-economical synthesis employs a two-step, one-pot strategy, eliminating intermediate purification and achieving an average yield of >85% per step. The optimized protocol, using six modified chiral monomers, enables precise stereochemical and sequence control. Thermal analysis revealed that stereochemistry significantly influences thermal transitions, including glass transition, crystallization, and melting behaviors. Tandem mass spectrometry provided in-depth sequencing analysis. We also demonstrated the post-synthetic modification of the SDOUs with dansyl chloride and explored their photophysical properties, such as solvatochromism and aggregation. Circular dichroism analysis highlighted their unique structural and conformational features. This approach establishes scalable, efficient synthetic routes for stereochemically controlled sequence-defined oligourethanes with diverse functional groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.